Search

everythinglearnresearchcommunity

for

Search:↓

Immune checkpoint inhibitors can cause skin issues but are linked to better cancer outcomes.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Coenzyme Q10 vesicular formulations can potentially treat androgenic alopecia by promoting hair growth and thickness.

Quick, selective detection of tadalafil and finasteride in human plasma developed.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Need better hair loss treatments beyond minoxidil, finasteride, and transplants.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

The weight loss drug Orlistat can cause liver damage and should be used with caution, especially in those with liver or kidney issues.

The document concludes that current hair loss treatments have limitations and suggests researching new treatments targeting different factors of hair loss.

The Accu-Chek FlexLink Plus and Accu-Chek LinkAssist Plus make insulin pump use safer, simpler, and more comfortable.

Minoxidil works well as a high permeability reference drug for biopharmaceutics classification.

Keratinocytes and adipose-derived stem cells can effectively heal difficult skin wounds.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Adalimumab is the most effective treatment for severe hidradenitis suppurativa, but more research is needed to improve treatment options.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

Hair loss treatments work better with lifestyle changes.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Ketoconazole cream is effective for skin conditions like seborrheic dermatitis and may help with hair loss and other skin issues, with generally mild side effects.

Melatonin solution helps treat hair loss in men and women.